ACA Pharma Named Exclusive Distributor for Ryanodex® and Barhemsys® in Hong Kong, Macau, Singapore, and Greater China

ACA Pharma has signed an exclusive distribution agreement with Eagle Pharmaceuticals to commercialize Ryanodex® (dantrolene sodium for injection), used for treating and preventing malignant hyperthermia, and Barhemsys® (amisulpride injection), for preventing and treating postoperative nausea and vomiting (PONV), across Hong Kong, Macau, Singapore, and Greater China. Ryanodex has completed fast-track registration in Macau, with Barhemsys ongoing, alongside filings in Hong Kong and Singapore; ACA is also purs ...